Hookipa Pharma Inc Reports Results For The Quarter Ended In March: Earnings Summary

Hookipa Pharma

09/05/2024 19:04

* HOOKIPA Pharma Inc  HOOK.OQ  reported quarterly adjusted
earnings of 11 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -27 cents.  The mean expectation of
four analysts for the quarter was for a loss of 10 cents per
share. Wall Street expected results to range from -18 cents
to -4 cents per share.
    * Revenue rose 1,052.4% to $36.60 million from a year ago;
analysts expected $2.80 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was 11
cents​.
    * The company reported quarterly net income of $14.38
million.
    * HOOKIPA Pharma Inc shares had risen by 12.4% this
quarter and
lost 1.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 12.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for HOOKIPA Pharma
Inc is $4.50 
This summary was machine generated from LSEG data May 9 at 06:04
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.10          0.11           Beat
 Dec. 31 2023      -0.19          -0.22          Missed
 Sep. 30 2023      -0.21          -0.17          Beat
 Jun. 30 2023      -0.21          -0.22          Missed